Edition:
India

Evolus Inc (EOLS.OQ)

EOLS.OQ on NASDAQ Stock Exchange Global Market

26.63USD
25 Apr 2019
Change (% chg)

$0.19 (+0.72%)
Prev Close
$26.44
Open
$26.63
Day's High
$26.63
Day's Low
$26.63
Volume
2,717
Avg. Vol
260,634
52-wk High
$39.50
52-wk Low
$6.78

Select another date:

Mon, Feb 4 2019

Photo

FDA approves cheaper Botox rival to treat frown lines

(This Feb. 1 story has been corrected to remove reference to dosage in paragraph 7)

CORRECTED-UPDATE 1-FDA approves cheaper Botox rival to treat frown lines (Feb.1)

Feb 1 An injection to treat forehead wrinkles is set to rival Allergan's Botox after U.S. regulators approved Evolus Inc's cheaper treatment on Friday, sending its shares up about 5 percent after the bell.

Select another date: